Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion type Assertion NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_head.
- NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion description "[To evaluate whether DLC-1 could be a therapeutic target for non-Hodgkin lymphoma (NHL), we examined the expressions of DLC-1 in Burkitt's lymphoma (BL) cell lines and tested the effects of DLC-1 on cellular growth and migration in BL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_provenance.
- NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion evidence source_evidence_literature NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_provenance.
- NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion SIO_000772 20882354 NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_provenance.
- NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion wasDerivedFrom befree-20140225 NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_provenance.
- NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_assertion wasGeneratedBy ECO_0000203 NP822094.RACbBG6NNn6cu9e_oMXQAfrfN4x2mHPYpc15LXnoF-IBo130_provenance.